Attached files

file filename
8-K - 8-K - Molycorp, Inc.a12-5620_18k.htm

Exhibit 99.1

 

 

For Release:  4:01 p.m. Eastern, February 23, 2012

 

MOLYCORP REPORTS RECORD FISCAL YEAR 2011 RESULTS

 

HIGHLIGHTS:

 

·                  Molycorp announced this week the successful launch of the sequential start-up of its new Project Phoenix rare earth manufacturing facility at Mountain Pass, which is ahead of schedule.

 

·                  The Company confirmed that Project Phoenix remains on its accelerated schedule, with a target of achieving a Phase 1 production run rate of 19,050 metric tons of rare earth oxide (REO) equivalent by the end of Q3 2012 (3 months earlier than originally planned) and Phase 2 mechanical completion by the end of Q4 2012 (6 months earlier than originally planned).

 

·                  2011 revenues were $396.8 million, up $361.7 million from 2010 revenues of $35.2 million.  2011 sales volumes at Mountain Pass increased 67% over 2010 levels, to 3,050 metric tons REO equivalent.  Consolidated sales across all segments reached 3,516 metric tons.

 

·                  Molycorp reported Q4 GAAP earnings per diluted share of $0.26, or $0.41 adjusted earnings per diluted share.  The Company also reported 2011 GAAP earnings per diluted share of $1.27, or $1.73 adjusted earnings per diluted share.  Adjusted EPS takes into account certain non-cash and other out-of-ordinary operational and business expansion items.

 

·                  The Company reported a $169.1 million increase in GAAP net income over the prior year.

 

Molycorp registered Q4 GAAP net sales revenue of $132.9 million, based on the sale of 886 metric tons of REO equivalent.  The Company also reported Q4 gross sales of $145.2 million based on 1,420 metric tons of REO equivalent products.

 

Greenwood Village, CO (February 23, 2011, 4:01 p.m. Eastern) — Molycorp, Inc. (NYSE: MCP) (“Molycorp” or the “Company”) today announced financial and operating results for the fourth quarter and full year 2011.

 

“2011 was a very successful year of accomplishment for Molycorp,” said Mark Smith, Molycorp President and Chief Executive Officer.  “We solidly turned the corner to profitability and we registered net sales of nearly $400 million.  We kept Project Phoenix tracking to an accelerated timeline, and succeeded in becoming the world’s first company outside of China to assemble a fully integrated rare earth mine-to-magnets supply chain.  We continue to produce and commercialize new products.  And, we remain laser-focused on ensuring that we are operating at peak performance so we can meet growing global demand for rare earths for years to come.”

 

“This Company is all about execution … about delivering what we said we would deliver,” Smith said. 
“I could not be more proud of the performance of the Molycorp family.”

 

1



 

QUARTERLY RESULTS

 

Quarterly net revenues were $132.9 million, down 3.7% from $138.0 million in the third quarter of 2011 and significantly higher than $21.7 million in the fourth quarter of 2010.  By contrast, Smith noted, a weighted basket(1) of rare earths — cerium oxide, lanthanum oxide, and didymium oxide — declined 47% over the Q3-Q4 period of 2011, according to prices published by Metal-Pages.com.  Molycorp sales volumes of cerium-based products sequentially grew 237%.

 

Gross profit was $70.3 million, a decrease of 14.7% from the third quarter of 2011 due primarily to higher raw material and chemical costs, and a slight change in product mix.  Gross margin of 52.9% decreased 6.8 percentage points compared to the prior quarter.

 

Operating income during the fourth quarter of 2011 was $46.0 million, down from operating income of $66.9 million during the third quarter of 2011.  The decrease was primarily attributed to higher costs of goods sold and higher general administrative costs. However, Q4 operating income was up significantly from an operating loss during the fourth quarter 2010 of $9.9 million.

 

Fourth quarter net income attributable to common stockholders was $26.6 million, or $0.26 per diluted share. Adjusted EPS of $0.41 per diluted share takes into account certain non-cash and other out-of-ordinary operational and business expansion items as compared to U.S. GAAP earnings per share.

 

RECORD FULL YEAR FINANCIAL PERFORMANCE

 

Net revenues for the full year ended December 31, 2011 were $396.8 million, up $361.7 million from $35.2 million for the full year ended December 31, 2010. The increase was due to higher volumes out of Mountain Pass, higher pricing, and expanded sales from the Silmet and MMA operations, which were acquired in the second quarter of 2011.

 

Gross profit was $218.9 million, a substantial increase compared to a gross loss of $2.4 million during the prior year.  Gross margin was 55.2% for the year, compared to a negative margin of 6.9% during 2010.

 

Operating income for the full year 2011 was $152.9 million, up from an operating loss of $51.2 million during the full year 2010.

 

The Company generated record full year 2011 net income attributable to common stockholders of $117.5 million, or $1.27 per diluted share, compared to a loss of $50.8 million, or $0.81 per diluted share in the prior period.  On a non-GAAP, adjusted basis, 2011 diluted earnings per share was $1.73.

 

2011/2012 MILESTONE ACHIEVEMENTS

 

Molycorp achieved a number of critical business and operational milestones in 2011, and into the opening weeks of 2012.  The Company:

 

·                  Formally launched the sequential start-up of its new Project Phoenix facility at Mountain Pass this week.

 


(1)   Weighted by relative revenues from 2011 sales.

 

2



 

·                 Active mining at a full mine production rate of approximately 2,800 short tons of fresh rare earth ore is in full swing and has been underway for several weeks.

 

·                  Mechanical completion of the new Crushing Facility has been achieved and the crusher is operational.

 

·                  Mechanical completion and steam testing of the initial Cracking Facility has been achieved and feedstock from stockpiled material has successfullys been fed into the system.

 

·                  The first test firing of the turbines in the onsite Combined Heat and Power (CHP) plant will occur this week.

 

·                  Assembled the components of its mine-to-magnets strategy by adding metal and alloy manufacturing capabilities, through acquisitions of its Molycorp Metals and Alloy and Molycorp Silmet subsidiaries, and by signing an agreement to form a joint venture with Daido Steel and Mitsubishi Corp. to manufacture permanent rare earth magnets. Construction of the magnet production facility is underway, and operations are expected to commence by the end of 2012.

 

·                  Achieved its 2011 contracting goal for Phase 1 production capacity, with 78% of Phase 1 being signed in customer agreements or reserved for XSORBX™ production.

 

·                  Sold a total of 55 metric tons of its proprietary cerium-based XSORBX™ products in 2011, and is on track to sell 20% of its Phase 1 production capacity through XSORBX™ products by the end of 2013.

 

·                  Entered into a three-year supply agreement with Hitachi Metals for rare earth magnetic materials, such as didymium metal and alloy, and lanthanum oxide.

 

·                  Made a strategic investment in Boulder Wind Power, which has developed a rare earth magnet powered wind turbine generator that relies on permanent rare earth magnets that require no dysprosium, a rare earth that is truly scarce in today’s markets.

 

·                  Increased our strategic flexibility through a $390 million capital investment commitment from Molymet.

 

2012 OUTLOOK

 

As of February 23, 2012, the Company is re-affirming its annual production of REO equivalent products to be in a range of 8,000 metric tons to 10,000 metric tons for the full year.  The Company believes it is positioned for year-over-year sales growth, given existing customer orders and a growing pipeline of global business opportunities.

 

The Company also anticipates a change to the cost of goods sold (COGS) related to Project Phoenix ramping, as well as higher production costs on a consolidated basis.  As a result of costs necessary to successfully prepare for the accelerated completion of Project Phoenix, the ramp up to Phase 1 production levels, and increased chemical costs, Molycorp is estimating that COGS will increase slightly in 2012 on a per-kilogram basis of REO equivalent.  Many of these increases however, are expected to normalize moving into 2013 when the Company reaches higher

 

3



 

production levels.  The Company added that it has sufficient working capital to execute on its stated strategy and its balance sheet remains strong.

 

Commenting on the new outlook, Smith continued, “Our primary focus remains on executing Project Phoenix and bringing a stable supply of rare earth products to global markets. As we begin the sequential start-up of Project Phoenix, we are shifting into a year of transition to test and ramp our new production capacity. We remain on track in making the necessary investments in our business, to improve our operating and financial performance, and deliver sustainable value for all Molycorp shareholders.”

 

CONFERENCE CALL TODAY AT 4:30 P.M. EASTERN

 

Molycorp will conduct a conference call today to discuss these results at 4:30 p.m. EST, hosted by Mark Smith, Chief Executive Officer, and Jim Allen, Chief Financial Officer.  Investors interested in participating in the live call from the U.S. should dial +1 (866) 543-6403 and reference passcode number 49932366. Those calling from outside the U.S. should dial +1 (617) 213-8896 and use the same confirmation number.  A telephone replay will be available approximately two hours after the call concludes through March 23, 2012 by dialing +1 (888) 286-8010 from the U.S., or +1 (617) 801-6888 from international locations, and entering passcode: 84743189.

 

There will also be a simultaneous live audio webcast available on the Investor Relations section of the Company’s website at www.molycorp.com/investors. The webcast will be archived on the website for 90 days.

 

4



 

FINANCIAL STATEMENTS AND SUPPLEMENTARY TABLES

 

MOLYCORP, INC.

 

(A Company in the Development Stage)

 

Condensed Consolidated Balance Sheets (Unaudited)

 

(In thousands, except share and per share amounts)

 

 

 

December 31, 2011

 

December 31, 2010

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

418,855

 

$

316,430

 

Trade accounts receivable

 

70,679

 

16,421

 

Inventory

 

111,943

 

18,822

 

Deferred charges

 

7,318

 

 

Prepaid income taxes

 

10,514

 

 

Prepaid expenses and other assets

 

19,735

 

1,759

 

Total current assets

 

639,044

 

353,432

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

Deposits

 

$

23,286

 

$

26,200

 

Property, plant and equipment, net

 

561,628

 

93,966

 

Inventory

 

4,362

 

5,212

 

Intangible assets, net

 

3,072

 

639

 

Investments

 

20,000

 

 

Goodwill

 

3,432

 

 

Other assets

 

301

 

111

 

Total non-current assets

 

616,081

 

126,128

 

Total assets

 

$

1,255,125

 

$

479,560

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Trade accounts payable

 

$

161,587

 

$

13,009

 

Accrued expenses

 

12,898

 

4,225

 

Deferred tax liabilities

 

1,356

 

 

Debt

 

1,516

 

 

Short-term borrowing - related party

 

870

 

3,085

 

Current portion of asset retirement obligation

 

396

 

393

 

Total current liabilities

 

178,623

 

20,712

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

Asset retirement obligation

 

$

15,145

 

$

12,078

 

Deferred tax liabilities

 

18,899

 

 

Debt

 

196,545

 

 

Other non-current liabilities

 

683

 

257

 

Total non-current liabilities

 

231,272

 

12,335

 

Total liabilities

 

$

409,895

 

$

33,047

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

Common stock, $0.001 par value; 350,000,000 shares authorized at December 31, 2011

 

84

 

82

 

Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011

 

2

 

 

Additional paid-in capital

 

838,547

 

539,866

 

Accumulated other comprehensive loss

 

(8,481

)

 

Surplus (deficit) accumulated during the development stage

 

15,078

 

(93,435

)

Total equity

 

845,230

 

446,513

 

Total liabilities and equity

 

$

1,255,125

 

$

479,560

 

 

5


 


 

MOLYCORP, INC.

 

(A Company in the Development Stage)

 

Consolidated Statements of Operations and Comprehensive Income

 

(In thousands, except share and per share amounts)

 

 

 

 

 

 

 

 

 

Total from

 

 

 

 

 

 

 

 

 

June 12, 2008

 

 

 

Year Ended December 31

 

(Inception) Through

 

 

 

2011

 

2010

 

2009

 

December 31, 2011

 

Sales

 

$

396,831

 

$

35,157

 

$

7,093

 

$

441,218

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

(177,890

)

(37,591

)

(21,785

)

(250,293

)

Selling, general and administrative (Includes stock-based compensation of $4,508 in 2011, $28,739 in 2010, $241 in 2009, and $33,638 from inception through December 31, 2011)

 

(64,387

)

(47,513

)

(12,685

)

(127,564

)

Depreciation and amortization

 

(733

)

(319

)

(191

)

(1,262

)

Accretion expense

 

(955

)

(912

)

(1,006

)

(3,123

)

Operating income (loss)

 

152,866

 

(51,178

)

(28,574

)

58,976

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Other income

 

(153

)

155

 

181

 

237

 

Foreign currency transaction losses, net

 

(5,415

)

 

 

(5,415

)

Interest (expense) income, net

 

(388

)

249

 

(194

)

(323

)

 

 

(5,956

)

404

 

(13

)

(5,501

)

Income (loss) before income taxes

 

146,910

 

(50,774

)

(28,587

)

53,475

 

Income tax expense

 

(28,576

)

 

 

(28,576

)

Net income (loss)

 

118,334

 

(50,774

)

(28,587

)

24,899

 

Net loss (income) attributable to noncontrolling interest

 

(808

)

 

 

(808

)

Net income (loss) attributable to Molycorp stockholders

 

$

117,526

 

$

(50,774

)

$

(28,587

)

$

24,091

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

118,334

 

$

(50,774

)

$

(28,587

)

$

24,899

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

(8,481

)

 

 

(8,481

)

Comprehensive income (loss)

 

$

109,853

 

$

(50,774

)

$

(28,587

)

$

16,418

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss) attributable to:

 

 

 

 

 

 

 

 

 

Molycorp stockholders

 

$

109,468

 

$

(50,774

)

$

(28,587

)

$

16,033

 

Noncontrolling interest

 

385

 

 

 

385

 

 

 

$

109,853

 

$

(50,774

)

$

(28,587

)

$

16,418

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

(Common shares) (1)

 

 

 

 

 

 

 

 

 

Basic

 

83,454,221

 

62,332,054

 

39,526,568

 

58,197,912

 

Diluted

 

85,220,017

 

62,332,054

 

39,526,568

 

58,694,839

 

Income (loss) per share of common stock :

 

 

 

 

 

 

 

 

 

Basic

 

$

1.29

 

$

(0.81

)

$

(0.72

)

$

0.24

 

Diluted

 

$

1.27

 

$

(0.81

)

$

(0.72

)

$

0.25

 

 


(1) Weighted average shares outstanding include the retroactive treatment of exchange ratios for conversion of Class A common stock and Class B common stock to common stock in conjunction with the initial public offering.

 

6



 

MOLYCORP, INC.

 

(A Company in the Development Stage)

 

Consolidated Statements of Cash Flows

 

(In thousands)

 

 

 

 

 

 

 

 

 

Total from

 

 

 

Year Ended

 

June 12, 2008

 

 

 

December 31,

 

(Inception) through

 

 

 

2011

 

2010

 

2009

 

December 31, 2011

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

118,334

 

$

(50,774

)

$

(28,587

)

$

24,899

 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

14,272

 

6,015

 

3,896

 

25,118

 

Amortization of convertible notes

 

674

 

 

 

674

 

Accretion of asset retirement obligation

 

955

 

912

 

1,006

 

3,123

 

Deferred income tax expense

 

2,924

 

 

 

2,924

 

Non-cash inventory write-downs

 

3,776

 

3,473

 

9,035

 

25,793

 

Non-cash share-based compensation expense

 

4,671

 

28,739

 

241

 

33,801

 

Impairment of fixed assets

 

 

3,114

 

 

3,114

 

Foreign currency transaction losses, net

 

5,415

 

 

 

5,415

 

Loss on disposal of fixed assets

 

1,296

 

 

 

1,296

 

Other operating adjustments

 

637

 

(59

)

2

 

580

 

Net change in operating assets and liabilities

 

(109,989

)

(20,137

)

(7,964

)

(142,200

)

 

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) operating activities

 

42,965

 

(28,717

)

(22,371

)

(15,463

)

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Acquisition of the Mountain Pass facility

 

 

 

 

(82,150

)

Cash paid in connection with acquisitions, net of cash acquired

 

(30,023

)

 

 

(30,023

)

Proceeds from sale of investment in joint venture

 

 

 

9,700

 

9,700

 

Cash paid to acquire non-marketable securities

 

(20,000

)

 

 

(20,000

)

Deposits

 

2,897

 

(26,200

)

 

(23,303

)

Capital expenditures

 

(302,180

)

(33,129

)

(7,285

)

(342,915

)

Other assets

 

(119

)

(111

)

 

(230

)

Proceeds from sale of assets

 

35

 

9

 

5

 

49

 

 

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

(349,390

)

(59,431

)

2,420

 

(488,872

)

 

 

 

 

 

 

 

 

 

 

Cash flows provided by financing activities:

 

 

 

 

 

 

 

 

 

Capital contributions from original stockholders

 

 

15,000

 

18,004

 

125,004

 

Repayments of short-term borrowings — related party

 

(3,150

)

(1,107

)

 

(4,257

)

Repayments of debt

 

(4,428

)

 

 

(4,428

)

Net proceeds from sale of common stock in conjunction with the initial public offering

 

 

378,633

 

 

378,633

 

Net proceeds from sale of preferred stock

 

199,642

 

 

 

199,642

 

Net proceeds from sale of convertible notes

 

223,100

 

 

 

223,100

 

Payments of financing costs

 

 

(185

)

 

(185

)

Payments of preferred dividends

 

(9,015

)

 

 

(9,015

)

Proceeds from exercise of options

 

 

300

 

50

 

350

 

Proceeds from short-term borrowings — related party

 

 

5,008

 

6,637

 

11,645

 

Proceeds from debt

 

5,131

 

 

 

5,131

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by financing activities

 

411,280

 

397,649

 

24,691

 

925,620

 

Effect of exchange rate changes on cash

 

(2,430

)

 

 

(2,430

)

Net change in cash and cash equivalents

 

102,425

 

309,501

 

4,740

 

418,855

 

Cash and cash equivalents at beginning of the period

 

316,430

 

6,929

 

2,189

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

418,855

 

$

316,430

 

$

6,929

 

$

418,855

 

 

7



 

SEGMENT INFORMATION

 

 

 

Molycorp
Mountain Pass
Year Ended
December 31,
2011

 

Molycorp
Sillamäe April 1,
2011 - December
31, 2011

 

Molycorp
Tolleson April 15,
2011 - December
31, 2011

 

Other

 

Eliminations

 

Total Molycorp,
Inc.

 

Year Ended December 31, 2011 (In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

External

 

$

253,563

 

$

86,496

 

$

56,772

 

$

 

$

 

$

396,831

 

Intersegment

 

55,155

 

13,902

 

 

 

(69,057

)

 

Total sales

 

308,718

 

100,398

 

56,772

 

 

 

 

 

 

Cost of goods sold

 

(78,890

)

(86,789

)

(53,826

)

 

41,615

 

(177,890

)

Selling, general and administrative expenses

 

(61,535

)

(2,499

)

(615

)

(530

)

792

 

(64,387

)

Depreciation, amortization and accretion expense

 

(1,378

)

(279

)

 

(31

)

 

(1,688

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

166,915

 

10,831

 

2,331

 

(561

)

(26,650

)

152,866

 

Other (expense) income

 

(287

)

(5,680

)

11

 

 

 

(5,956

)

Income (loss) before income taxes

 

$

166,628

 

$

5,151

 

$

2,342

 

$

(561

)

$

(26,650

)

$

146,910

 

Total assets at December 31, 2011

 

$

1,249,998

 

$

118,001

 

$

30,061

 

$

794

 

$

(143,729

)

$

1,255,125

 

Capital expenditures (accrual basis excluding capitalized interest)

 

$

401,047

 

$

8,170

 

$

 

$

 

$

 

$

409,217

 

 

EARNINGS PER SHARE

 

 

 

 

 

Total from

 

 

 

 

 

June 12, 2008

 

 

 

Year

 

(Inception)

 

 

 

Ended

 

Through

 

 

 

December 31,

 

December 31,

 

(In thousands, except share and per share amounts)

 

2011

 

2011

 

Net income attributable to Molycorp stockholders

 

$

117,526

 

$

24,091

 

Cumulative undeclared and paid dividends on preferred stock

 

(9,962

)

(9,962

)

Net income attributable to common stockholders

 

107,564

 

14,129

 

Weighted average common shares outstanding—basic

 

83,454,221

 

58,197,912

 

Basic earnings per share

 

$

1.29

 

$

0.24

 

 

 

 

 

 

 

Net income attributable to common stockholders

 

$

107,564

 

$

14,129

 

Effect of dilutive Notes

 

413

 

413

 

Income attributable to common stockholders, adjusted for the effect of dilutive Notes

 

107,977

 

14,542

 

Weighted average common shares outstanding—dilutive

 

85,220,017

 

58,694,839

 

Dilutive earnings per share

 

$

1.27

 

$

0.25

 

 

8



 

PRODUCT REVENUE / VOLUME / ASP TABLE

 

Product Revenues, Volumes

 

 

 

Twelve Months Ended
December 31,

 

Three Months
Ended

 

Revenues (in thousands)

 

2011

 

2010

 

Dec 31, 2011

 

REO Equivalent Products

 

 

 

 

 

 

 

Didymium Products

 

$

101,410

 

$

9,020

 

$

32,654

 

Neodymium Products

 

27,426

 

18

 

9,035

 

Praseodymium Products

 

7,557

 

171

 

2,527

 

Lanthanum Products

 

91,702

 

13,758

 

22,494

 

Cerium Products

 

59,825

 

10,143

 

13,846

 

Other REO Products

 

5,108

 

2,047

 

530

 

Rare Earth Alloys

 

48,388

 

 

28,940

 

Subtotal REO Equivalent

 

341,416

 

35,157

 

110,026

 

 

 

 

 

 

 

 

 

Rare Metals (Nb, Ta)

 

46,280

 

 

19,423

 

Other

 

9,135

 

 

3,457

 

Total Net Revenues

 

$

396,831

 

$

35,157

 

$

132,906

 

 

 

 

Twelve Months Ended
December 31,

 

Three Months
Ended

 

Volumes (in metric tons)

 

2011

 

2010

 

Dec 31, 2011

 

REO Equivalent Products

 

 

 

 

 

 

 

Didymium Products

 

539

 

197

 

166

 

Neodymium Products

 

137

 

 

50

 

Praseodymium Products

 

52

 

4

 

17

 

Lanthanum Products

 

1,830

 

1,305

 

382

 

Cerium Products

 

772

 

252

 

219

 

Other REO Products

 

39

 

72

 

0

 

Rare Earth Alloys

 

147

 

 

52

 

Subtotal REO Equivalent

 

3,516

 

1,830

 

886

 

 

 

 

 

 

 

 

 

Rare Metals

 

260

 

 

92

 

Other

 

3,182

 

 

616

 

Total Product Volumes

 

6,958

 

1,830

 

1,594

 

 

 

 

Twelve Months Ended
December 31,

 

Three Months
Ended

 

Avg Selling Price per kg

 

2011

 

2010

 

Dec 31, 2011

 

REO Equivalent Products

 

 

 

 

 

 

 

Didymium Products

 

$

188

 

$

46

 

$

197

 

Neodymium Products

 

$

200

 

$

 

$

180

 

Praseodymium Products

 

$

146

 

$

43

 

$

149

 

Lanthanum Products

 

$

50

 

$

11

 

$

59

 

Cerium Products

 

$

77

 

$

40

 

$

63

 

Other REO Products

 

$

131

 

$

28

 

$

2,120

 

Rare Earth Alloys

 

$

329

 

$

 

$

555

 

Subtotal REO Equivalent

 

$

97

 

$

19

 

$

124

 

 

 

 

 

 

 

 

 

Rare Metals

 

$

178

 

$

 

$

211

 

Other

 

$

3

 

$

 

$

6

 

Average selling price

 

nm

 

nm

 

nm

 

 

nm = not material

 

9



 

NON-GAAP ADJUSTED NET INCOME

 

Adjusted EPS is a non-GAAP measure that excludes certain non-cash items and other out-of-ordinary operational and business expansion items. The Company’s management believes adjusting out these items, including but not limited to purchase accounting adjustments, stock-based compensation, out-of-ordinary expenses/income and other miscellaneous charges is useful to investors because it provides an overall understanding of the Company’s historical financial performance and future prospects. Management believes adjusted EPS is an indication of the Company’s base-line performance. Exclusion of these items permits evaluation and comparison of results for the Company’s core business operations, and it is on this basis that management internally assesses the Company’s performance.

 

Molycorp, Inc.

Non-GAAP financial measures

Adjusted Net Income (Loss)

 

 

 

Year ended

 

Three months
 ended

 

 

 

December 31,

 

December 31,

 

(in thousands, except per share data)

 

2011

 

2011

 

Net income (loss) attributable to Molycorp stockholders

 

$

117,526

 

$

26,579

 

Certain non-cash items:

 

 

 

 

 

Stock-based compensation

 

4,508

 

586

 

Inventory write-downs

 

3,776

 

2,191

 

Impact of purchase accounting on cost of inventory sold (1)

 

10,226

 

 

Net (gain)/loss on asset sales

 

1,243

 

1,206

 

 

 

 

 

 

 

Out of the ordinary items:

 

 

 

 

 

Water removal

 

6,222

 

5,181

 

Revenue sharing agreement

 

8,581

 

3,952

 

Project Phoenix non-capitalizable costs

 

780

 

514

 

Organization and operations consulting costs

 

4,347

 

 

 

 

 

 

 

 

Business Expansion items:

 

 

 

 

 

Due diligence and other transaction expenses

 

6,978

 

2,023

 

Other business expansion expenses

 

10,515

 

4,449

 

Income tax effect of above adjustments (2)

 

(17,456

)

(6,985

)

Adjusted net income (loss)

 

$

157,246

 

$

39,696

 

Cumulative paid and undeclared dividends on preferred stock

 

(9,962

)

(3,795

)

Effect of dilutive 3.25% Convertible Notes

 

413

 

 

Adjusted net income (loss) attributed to common stockholders for dilutive EPS purposes

 

147,697

 

35,901

 

Weighted average diluted shares outstanding

 

85,220,017

 

87,069,711

 

Adjusted diluted net income (loss) per share of common stock

 

$

1.73

 

$

0.41

 

 


(1) Purchase price adjustment to Molycorp Sillamäe’s inventory related to inventory sold as of 9/30/2011.

 

(2) The income tax effects for the three-months and the year ended December 31, 2011, were calculated using the combined statutory U.S. federal and state (net of federal benefit) tax rate of 39% applied to the total of all adjustments attributable to the Company’s operations in the United States. All adjustments are attributable to the Company’s U.S. operations, except for the impact of purchase accounting on cost of inventory sold, which is attributable to the Company’s operation in Sillamäe, Estonia.

 

10



 

NON-GAAP GROSS SALES

 

Gross sales is a non-GAAP measure that is included to provide additional detail on segment operations and vertical integration strategy. The Company’s management believes this presentation provides a better understanding of the performance of each operating segment in terms of production volumes, inventory allocation, and costs.

 

Year Ended December 31, 2011
(In thousands)

 

Molycorp
Mountain Pass
Year Ended
December 31,
2011

 

Molycorp
Sillamäe April 1,
2011 - December
31, 2011

 

Molycorp
Tolleson April 15,
2011 - December
31, 2011

 

Total Molycorp,
Inc.

 

Sales:

 

 

 

 

 

 

 

 

 

Sales net of intercompany transfers

 

$

253,563

 

$

86,496

 

$

56,772

 

$

396,831

 

Intersegment

 

55,155

 

13,902

 

 

 

Total gross sales

 

$

308,718

 

$

100,398

 

$

56,772

 

$

465,888

 

 

Three Months Ended December 31, 2011
(In thousands)

 

Molycorp
Mountain Pass

 

Molycorp
Sillamäe

 

Molycorp
Tolleson

 

Total Molycorp,
Inc.

 

Sales:

 

 

 

 

 

 

 

 

 

Sales net of intercompany transfers

 

$

72,613

 

$

28,219

 

$

32,073

 

$

132,905

 

Intersegment

 

8,672

 

3,612

 

 

12,284

 

Total gross sales

 

$

81,285

 

$

31,831

 

$

32,073

 

$

145,189

 

 

# #  #

 

FOR MORE INFORMATION:

 

Company Contacts:

 

Jim Sims, +1 (303) 843-8062

Vice President Corporate Communications

Jim.Sims@Molycorp.com

 

Brian Blackman, +1 (303) 843-8067

Senior Manager, Investor Relations

Brian.Blackman@Molycorp.com

 

11



 

ABOUT MOLYCORP

 

With offices in the U.S., Europe, and Japan, Molycorp, Inc. is the largest REO producer outside of China.  In addition to its current production of rare earth oxides at its flagship rare earth mine and processing facility at Mountain Pass, California, the Company produces rare earth metals, rare earth alloys (such as neodymium- iron-boron and samarium-cobalt alloys) and rare metals such as niobium and tantalum. The rare earths and rare metals Molycorp produces are critical inputs in existing and emerging applications including: clean energy technologies, such as hybrid and electric vehicles and wind power turbines; multiple high-tech uses, including fiber optics, lasers and hard disk drives; numerous defense applications, such as guidance and control systems and global positioning systems; advanced water treatment technology for use in industrial, military and outdoor recreation applications; and other technologies. For more information, please visit http://www.molycorp.com.

 

SAFE HARBOR STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This release contains forward-looking statements that represent Molycorp’s beliefs, projections and predictions about future events or Molycorp’s future performance. Forward-looking statements can be identified by terminology such as “may,” “will,” “would,” “could,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or the negative of these terms or other similar expressions or phrases. These forward-looking statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause Molycorp’s actual results, performance or achievements or industry results to differ materially from any future results, performance or achievement described in or implied by such statements.

 

Factors that may cause actual results to differ materially from expected results described in forward-looking statements include, but are not limited to: Molycorp’s ability to secure additional capital to implement its business plans; Molycorp’s ability to complete its  initial modernization and expansion efforts, including the accelerated start-up of the Mountain Pass facility, which management refers to as Project Phoenix Phase 1, and the second phase capacity expansion plan, which management refer to as Project Phoenix Phase 2, and reach full planned production rates for REOs and other planned downstream products, in each case within the projected timeframe; the final costs of the Project Phoenix Phase 1, including with accelerated start-up of the Mountain Pass facility, and Project Phoenix Phase 2, which may differ from estimated costs; uncertainties associated with Molycorp’s reserve estimates and non-reserve deposit information; uncertainties regarding global supply and demand for rare earths materials; Molycorp’s ability to successfully integrate recently acquired businesses; Molycorp’s ability to reach definitive agreements for a joint venture to manufacture neodymium-iron-boron permanent rare earth magnets; the satisfaction of the closing conditions necessary to complete Molymet’s investment, including our receipt of necessary government regulatory approvals; Molycorp’s ability to maintain appropriate relations with unions and employees; Molycorp’s ability to successfully implement its “mine-to-magnets” strategy; environmental laws, regulations and permits affecting Molycorp’s business, directly and indirectly, including, among others, those relating to mine reclamation and restoration, climate change, emissions to the air and water and human exposure to hazardous substances used, released or disposed of by Molycorp; and uncertainties associated with unanticipated geological conditions related to mining.

 

For more information regarding these and other risks and uncertainties that Molycorp may face, see the section entitled “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended

 

12



 

December 31, 2011 and of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2011. Any forward-looking statement contained in this press release or the Annual Report on Form 10-K or the Quarterly Report on Form 10-Q reflects Molycorp’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Molycorp’s operations, operating results, growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak only as to the date when made. Molycorp assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, except as otherwise required by applicable law.

 

13